Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial
PaperCitations, authors & open-access status
Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 69 citations, 2014 year and bronze oa status.
69
Citations
2014
Year
bronze
OA Status